BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26633478)

  • 21. Update on the management of refractory coeliac disease.
    Al-Toma A; Verbeek WH; Mulder CJ
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):57-63. PubMed ID: 17410290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refractory coeliac disease a reality: views from Pakistan.
    Mandhwani RM; Wadhwa RK; Laeeq SM; Luck NH; Mubarak M; Majid Z
    Trop Doct; 2017 Jan; 47(1):51-53. PubMed ID: 26917496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue.
    Daum S; Weiss D; Hummel M; Ullrich R; Heise W; Stein H; Riecken EO; Foss HD;
    Gut; 2001 Dec; 49(6):804-12. PubMed ID: 11709515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease.
    van Wanrooij RL; Müller DM; Neefjes-Borst EA; Meijer J; Koudstaal LG; Heideman DA; Bontkes HJ; von Blomberg BM; Bouma G; Mulder CJ
    J Clin Immunol; 2014 Oct; 34(7):828-35. PubMed ID: 25062848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of refractory coeliac disease.
    Woodward J
    Ther Adv Chronic Dis; 2013 Mar; 4(2):77-90. PubMed ID: 23556127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease.
    Hussein S; Gindin T; Lagana SM; Arguelles-Grande C; Krishnareddy S; Alobeid B; Lewis SK; Mansukhani MM; Green PHR; Bhagat G
    J Clin Pathol; 2018 Sep; 71(9):825-831. PubMed ID: 29703761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory celiac disease.
    Rishi AR; Rubio-Tapia A; Murray JA
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):537-46. PubMed ID: 26603931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refractory celiac disease: from bench to bedside.
    Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
    Semin Immunopathol; 2012 Jul; 34(4):601-13. PubMed ID: 22810901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Budesonide Induces Favourable Histologic and Symptomatic Recovery in Patients with Non-responsive and Refractory Coeliac Disease When Given in an Open Capsule Format.
    Saitta D; Henneken LM; Apputhurai P; Chen Yi Mei SL; Tye-Din JA
    Dig Dis Sci; 2024 Apr; ():. PubMed ID: 38683433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coeliac disease.
    Glissen Brown JR; Singh P
    Paediatr Int Child Health; 2019 Feb; 39(1):23-31. PubMed ID: 30099930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiologic and therapeutic aspects of refractory coeliac disease - a systematic review.
    Rowinski SA; Christensen E
    Dan Med J; 2016 Dec; 63(12):. PubMed ID: 27910801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory celiac disease.
    Abdallah H; Leffler D; Dennis M; Kelly CP
    Curr Gastroenterol Rep; 2007 Oct; 9(5):401-5. PubMed ID: 17991341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open-Capsule Budesonide for Refractory Celiac Disease.
    Mukewar SS; Sharma A; Rubio-Tapia A; Wu TT; Jabri B; Murray JA
    Am J Gastroenterol; 2017 Jun; 112(6):959-967. PubMed ID: 28323276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of molecular markers in the diagnosis of refractory coeliac disease in a large patient cohort.
    O'Shea U; Abuzakouk M; O'Morain C; O'Donoghue D; Sheahan K; Watson P; O'Briain S; Alexander D; Catherwood M; Jackson J; Kelly J; Feighery C
    J Clin Pathol; 2008 Nov; 61(11):1200-2. PubMed ID: 18955575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
    Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms and management of refractory coeliac disease.
    van Gils T; Nijeboer P; van Wanrooij RL; Bouma G; Mulder CJ
    Nat Rev Gastroenterol Hepatol; 2015 Oct; 12(10):572-9. PubMed ID: 26347156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel variant of EATL evolving from mucosal γδ-T-cells in a patient with type I RCD.
    van Wanrooij RL; de Jong D; Langerak AW; Ylstra B; van Essen HF; Heideman DA; Bontkes HJ; Mulder CJ; Bouma G
    BMJ Open Gastroenterol; 2015; 2(1):e000026. PubMed ID: 26462278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease.
    Di Sabatino A; Giuffrida P; Vanoli A; Luinetti O; Manca R; Biancheri P; Bergamaschi G; Alvisi C; Pasini A; Salvatore C; Biagi F; Solcia E; Corazza GR
    Am J Gastroenterol; 2014 Feb; 109(2):258-69. PubMed ID: 24394748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enteropathy-associated T-cell lymphoma. Manifestation as diet-refractory coeliac disease and ulcerating jejunitis].
    Bächle T; Rühl U; Ott G; Walker S
    Dtsch Med Wochenschr; 2001 Dec; 126(51-52):1460-3. PubMed ID: 11753737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients.
    Hollon JR; Cureton PA; Martin ML; Puppa EL; Fasano A
    BMC Gastroenterol; 2013 Feb; 13():40. PubMed ID: 23448408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.